Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
184.87
-3.21 (-1.71%)
At close: Mar 6, 2026, 4:00 PM EST
185.20
+0.33 (0.18%)
After-hours: Mar 6, 2026, 6:54 PM EST
Biogen Stock Forecast
Stock Price Forecast
The 25 analysts with 12-month price forecasts for Biogen stock have an average target of 194.72, with a low estimate of 115 and a high estimate of 255. The average target predicts an increase of 5.33% from the current stock price of 184.87.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock from 27 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 8 |
| Buy | 5 | 5 | 4 | 4 | 5 | 4 |
| Hold | 16 | 14 | 13 | 11 | 13 | 14 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 27 | 25 | 23 | 22 | 24 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Initiates $185 | Hold | Initiates | $185 | +0.07% | Feb 20, 2026 |
| Wedbush | Wedbush | Hold Maintains $178 → $187 | Hold | Maintains | $178 → $187 | +1.15% | Feb 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $220 → $230 | Strong Buy | Maintains | $220 → $230 | +24.41% | Feb 9, 2026 |
| BMO Capital | BMO Capital | Hold Maintains $165 → $196 | Hold | Maintains | $165 → $196 | +6.02% | Feb 9, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $157 → $177 | Hold | Maintains | $157 → $177 | -4.26% | Feb 9, 2026 |
Financial Forecast
Revenue This Year
9.62B
from 9.89B
Decreased by -2.71%
Revenue Next Year
9.54B
from 9.62B
Decreased by -0.86%
EPS This Year
16.08
from 8.79
Increased by 82.92%
EPS Next Year
16.63
from 16.08
Increased by 3.45%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.4B | 10.7B | |||
| Avg | 9.6B | 9.5B | |||
| Low | 9.0B | 8.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.0% | 10.8% | |||
| Avg | -2.7% | -0.9% | |||
| Low | -9.1% | -11.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 17.14 | 21.95 | |||
| Avg | 16.08 | 16.63 | |||
| Low | 14.05 | 13.51 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 94.9% | 36.5% | |||
| Avg | 82.9% | 3.5% | |||
| Low | 59.9% | -16.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.